Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The man was diagnosed with Cronkhite-Canada syndrome, a rare disorder with GI polyps, skin issues, hair loss, and nail problems.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Targeting specific T cells may help treat alopecia areata.

Treatment improved some symptoms but not all.

Corkscrew hair may be a new sign for quickly diagnosing scalp fungus in black children.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Thallium poisoning can cause severe neurological symptoms and hair loss.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Epidermolysis bullosa is a genetic disease causing fragile skin and blisters in both animals and humans.

Orange spots in scalp trichoscopy can help diagnose scalp sarcoidosis.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Stem cells are key for hair follicle recovery.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Lithium treatment can cause increased hair shedding and hair loss in patients.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Human hair follicles can regenerate and recover after severe injury by going through a brief abnormal resting phase before growing again.

Vitamin D and calcium are essential for normal hair growth.

High levels of the seizure medication sodium valproate can cause hair loss.

Sulfur mustard damages hair follicles and sebaceous glands in mice.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

A new severe form of monilethrix syndrome includes hair loss, scalp itching, cataracts, and distinct facial features.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.